Trial NC-HEM-17-4


A Phase 3, Randomized, Open-label, active-controlled study of ALXN1210 versus Eculizumab in adult patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) currently treated with Eculizumab

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Caroline Piatek, M.D.
Other Trial Staff:  John Lee, D.M., Suraj Chandwani, D.M., Ashot Minasyan, D.M., Christine Duran, Coordinator, Ibrahim Syed, Coordinator, Donna Fernando, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.